Larson Financial Group
AUPH icon

Larson Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Larson Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.5K Buy
1,883
+1,261
+203% +$20.1K ﹤0.01% 1855
2026
Q2 		$10.6K Buy
622
+7
+1% +$112 ﹤0.01% 2372
2026
Q1 		$9.11K Buy
615
+273
+80% +$3.99K ﹤0.01% 2299
2025
Q4 		$5.46K Buy
342
+13
+4% +$184 ﹤0.01% 2423
2025
Q3 		$3.64K Buy
+329
New +$3.59K ﹤0.01% 2475

Other funds holding AUPH

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Hussman Strategic Advisors
Hussman Strategic Advisors Ellicott City, Maryland $469M AUM 10.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Larson Financial Group's AUPH Position: Q3 2026 in Review

Larson Financial Group increased its Aurinia Pharmaceuticals (AUPH) stake by 203% in Q3 2026, buying an estimated $20.1K and bringing the position to 1,883 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Larson Financial Group first reported a position in AUPH in Q3 2025 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Larson Financial Group held 1,883 shares of Aurinia Pharmaceuticals worth $30.5K as of Q3 2026.
  • Larson Financial Group bought 1,261 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $20.1K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1855 holding.
  • Larson Financial Group first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 102 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.